Inflammation and Alzheimer's disease: Possible role of periodontal diseases

[1]  Patrick L. McGeer,et al.  NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies , 2007, Neurobiology of Aging.

[2]  S. Rivest,et al.  Role of IL-1 and TNF in the brain: Twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system , 2007, Brain, Behavior, and Immunity.

[3]  R. Müller,et al.  Treponema denticola in Disseminating Endodontic Infections , 2006, Journal of dental research.

[4]  James A. Mortimer,et al.  Potentially modifiable risk factors for dementia in identical twins , 2006, Alzheimer's & Dementia.

[5]  B. Reisberg,et al.  Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment , 2006, Neurobiology of Aging.

[6]  K. Kornman.  Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. , 2006, The American journal of clinical nutrition.

[7]  R. Martins,et al.  Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes , 2006, Neurobiology of Aging.

[8]  T. Kawai,et al.  Immune Response: The Key to Bone Resorption in Periodontal Disease. , 2005, Journal of periodontology.

[9]  J. Beck,et al.  Systemic Effects of Periodontitis: Epidemiology of Periodontal Disease and Cardiovascular Disease. , 2005, Journal of periodontology.

[10]  D. Praticò,et al.  Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti‐inflammatory drugs , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  R. Ellen,et al.  Spirochetes at the forefront of periodontal infections. , 2005, Periodontology 2000.

[12]  L. Thal,et al.  A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment , 2005, Neuropsychopharmacology.

[13]  Ryan T Demmer,et al.  Periodontal Microbiota and Carotid Intima-Media Thickness: The Oral Infections and Vascular Disease Epidemiology Study (INVEST) , 2005, Circulation.

[14]  J. Eugenín,et al.  Microglial reactivity to β-amyloid is modulated by astrocytes and proinflammatory factors , 2004, Brain Research.

[15]  D. Appelt,et al.  Infiltration of the brain by pathogens causes Alzheimer’s disease , 2004, Neurobiology of Aging.

[16]  A. Hofman,et al.  Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. , 2004, Archives of neurology.

[17]  M. Ide,et al.  The Short‐Term Effects of Treatment of Chronic Periodontitis on Circulating Levels of Endotoxin, C‐Reactive Protein, Tumor Necrosis Factor‐α, and Interleukin‐6 , 2004 .

[18]  F. Scannapieco,et al.  Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review. , 2003, Annals of periodontology.

[19]  S. Socransky,et al.  Relationship of destructive periodontal disease to the acute-phase response. , 2003, Journal of periodontology.

[20]  Veikko Salomaa,et al.  Antibodies to Periodontal Pathogens Are Associated With Coronary Heart Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[21]  K. Davis,et al.  Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. , 2003, JAMA.

[22]  V. Perry,et al.  Systemic infection, interleukin 1β, and cognitive decline in Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[23]  S. Rivest.  Molecular insights on the cerebral innate immune system , 2003, Brain, Behavior, and Immunity.

[24]  R. Schmidt,et al.  Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study , 2002, Annals of neurology.

[25]  J. Albandar.  Periodontal diseases in North America. , 2002, Periodontology 2000.

[26]  G. Riviere,et al.  Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. , 2002, Oral microbiology and immunology.

[27]  G. Taylor.  Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. , 2001, Annals of periodontology.

[28]  Patrick L. McGeer,et al.  Inflammation, autotoxicity and Alzheimer disease , 2001, Neurobiology of Aging.

[29]  A. Hofman,et al.  Antihypertensive drugs and incidence of dementia: the Rotterdam Study , 2001, Neurobiology of Aging.

[30]  McGeer Eg,et al.  Innate immunity in Alzheimer's disease: a model for local inflammatory reactions. , 2001 .

[31]  K. Okuda,et al.  Detection of Treponema denticola in Atherosclerotic Lesions , 2001 .

[32]  R. Dantzer,et al.  Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? , 2000, Autonomic Neuroscience.

[33]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[34]  G. Roberts,et al.  Odontogenic bacteremia following tooth cleaning procedures in children. , 2000, Pediatric dentistry.

[35]  L. Murray,et al.  Association of interleukin‐1 gene polymorphisms with Alzheimer's disease , 2000, Annals of neurology.

[36]  J. Pankow,et al.  Acute-phase Inflammatory Response to Periodontal Disease in the US Population , 2000, Journal of dental research.

[37]  L. Nee,et al.  Alzheimer’s Disease in 22 Twin Pairs – 13-Year Follow-Up: Hormonal, Infectious and Traumatic Factors , 1999, Dementia and Geriatric Cognitive Disorders.

[38]  N. Delanty,et al.  Risk of Alzheimer's disease and duration of NSAID use , 1998, Neurology.

[39]  D. Appelt,et al.  Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain , 1998, Medical Microbiology and Immunology.

[40]  Z. Janka,et al.  Serum interleukin‐6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease , 1997, Acta neurologica Scandinavica.

[41]  R. Page,et al.  The host response to the microbial challenge in periodontitis: assembling the players. , 1997, Periodontology 2000.

[42]  P. Hedera,et al.  Delirium in Alzheimer Disease , 1997, Alzheimer disease and associated disorders.

[43]  N. Rothwell,et al.  Local cytokine induction by LPS in the rat air pouch and its relationship to the febrile response. , 1997, The American journal of physiology.

[44]  S. Offenbacher.  Periodontal diseases: pathogenesis. , 1996, Annals of periodontology.

[45]  P. Mcgeer,et al.  Anti‐Inflammatory Drugs in the Fight against Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.

[46]  G. Swart,et al.  Pericarditis, pneumonia and brain abscess due to a combined Actinomyces--Actinobacillus actinomycetemcomitans infection. , 1992, The Journal of infection.

[47]  A. van Dam,et al.  (Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. , 2007, Clinical science.

[48]  M. Ide,et al.  The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. , 2004, Journal of periodontology.

[49]  T. Harris,et al.  The metabolic syndrome, inflammation, and risk of cognitive decline. , 2004, JAMA.

[50]  A. Dasanayake,et al.  Preterm low birth weight and periodontal disease among African Americans. , 2003, Dental clinics of North America.

[51]  S. Socransky,et al.  Dental biofilms: difficult therapeutic targets. , 2002, Periodontology 2000.

[52]  P. Mcgeer,et al.  Innate immunity in Alzheimer's disease: a model for local inflammatory reactions. , 2001, Molecular interventions.

[53]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.